Sign In  |  Register  |  About Burlingame  |  Contact Us

Burlingame, CA
September 01, 2020 10:18am
7-Day Forecast | Traffic

  • Search Hotels in Burlingame

  • CHECK-IN:
  • CHECK-OUT:
  • ROOMS:
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries
Business Exposures
< Previous 1 2
...
13 14 15 16 17 18 19 20 21
...
99 100 Next >
Actinium Pharmaceuticals Receives FDA Request For Additional Studies On Leukemia Treatment
Via Benzinga
Exposures Product Safety
Tickers ATNM
FDA Panel Backs Zevra's Arimoclomol For Rare Genetic Disorder, Analyst Highlights Balanced Portfolio Of Marketed Products And Pipeline Assets Focused On Rare Diseases
Via Benzinga
Exposures Product Safety
Tickers ZVRA
EXCLUSIVE: Alzamend Neuro To Assess AL001 Alzheimer's Candidate Against Commonly Marketed Lithium Salt In Phase 2 Head-To-Head Study
Via Benzinga
Exposures Product Safety
Tickers ALZN
Mental Health Watchdog Urges FDA to Ban Electroshock Device
Via Press Release Distribution Service
Exposures Product Safety
Intelligent Bio Solutions Inc. (Nasdaq: INBS) Announces Major Steps Towards FDA Clearance and U.S. Launch.
Via AB Newswire
Exposures Product Safety
Tickers INBS
MDC Associates Combines IVD Expertise with CRO Services Excellence at ADLM 2024
Via Press Release Distribution Service
Exposures Product Safety
Lucid Stock Warning: LCID Offers Little Upside Ahead. Steer Clear.
Via InvestorPlace
Topics Product Recall
Exposures Legal Product Safety
Tickers LCID TSLA
BioMedNewsBreaks — CEL-SCI Corp. (NYSE American: CVM) Closes on $10.8M Best-Efforts Offering
Via Investor Brand Network
Exposures Product Safety
Tickers CVM
FDA Approves Adaptimmune Therapeutics' Engineered Cell Therapy As First For Solid Tumor And New Therapy For Rare Soft Tissue Cancer In Over A Decade
Via Benzinga
Exposures Product Safety
Tickers ADAP GLPG
Boar’s Head Recalls 2024: 7 Million Pounds of Deli Meat, Poultry Pulled
Via InvestorPlace
Topics Product Recall
Exposures Legal Product Safety
Tickers FFIE INTC SAVE
Ground Cinnamon Recalls: What to Know as FDA Issues Alert Over Lead Levels
Via InvestorPlace
Topics Product Recall
Exposures Legal Product Safety
Tickers ASML FGEN
Zynex Inc. CEO Thomas Sandgaard Discusses Significant Company Growth and Future Innovations
Via News Direct
Exposures Product Safety
Mainz Biomed's (NASDAQ: MYNZ) Cutting-Edge Colorectal Cancer Test Applies For FDA Breakthrough Status
Via News Direct
Topics Artificial Intelligence
Exposures Artificial Intelligence Product Safety
Tickers MYNZ
E-Commerce Giant Amazon Ordered To Recall Over 400K Hazardous Products Sold On Its Site By US Federal Agency
Via Benzinga
Topics Product Recall
Exposures Legal Product Safety
Tickers AMZN
Alignment with FDA on Pediatric Study Plan and Accelerated Approval to Treat Bipolar Depression and Akathisia: NRx Pharmaceuticals, Inc. (Nasdaq: NRXP)
Via Get News
Exposures Product Safety
Tickers NRXP
FDA Warns Of Overdose Risks With Compounded Wegovy, Ozempic Injections
Via Benzinga
Exposures Product Safety
Tickers NVO
Acarix announces shares are now being traded on the OTCQB under the ticker ACIXF
Via News Direct
Exposures Product Safety
Family Vision Optical Welcomes Dr. Amanda Bancroft to Their Eye Care Team
Via Press Advantage
Topics Product Recall
Exposures Legal Product Safety
TSLA Stock Drops as Tesla Recalls 1.8 Million EVs Over Hood Issue
Via InvestorPlace
Topics Product Recall
Exposures Legal Product Safety
Tickers DAL SA SOFI TSLA
InvestorNewsBreaks – Processa Pharmaceuticals Inc.’s (NASDAQ: PCSA) IND Application for Phase 2 Clinical Trial of NGC-Cap in Patients with Breast Cancer Receives FDA Clearance
Via Investor Brand Network
Exposures Product Safety
Tickers PCSA
Movano Evie Ring Could Soon Get FDA Clearance, Analyst Says: 'A Validated Wearable Device Truly Opens The Market'
Via Benzinga
Exposures Product Safety
Tickers MOVE
Annovis Bio Inc. (NYSE: ANVS) Announces FDA Approval to Transition to New Form of Buntanetap for Future Clinical Trials
Via Investor Brand Network
Topics Intellectual Property
Exposures Intellectual Property Product Safety
Tickers ANVS
Merck's Q2 Earnings: Revenue And EPS Beat Helped By Strong Keytruda Sales, But Acquisition Costs Bites Into Annual Profit Forecast
Via Benzinga
Exposures Product Safety
Tickers DSKYF DSNKY MRK
Tesla Recalls Over 1.8M Vehicles Over Concerns Of Unlatched Hood Opening When Driving
Via Benzinga
Topics Product Recall
Exposures Legal Product Safety
Tickers TSLA
Art Installation Near White House Urges FDA To Approve MDMA-Assisted Therapy For Veterans As Decision Time Looms
Via Benzinga
Exposures Product Safety
FDA Greenlights Guardant Health's Shield Blood Test, Analyst Cautious on Adoption
Via Benzinga
Exposures Product Safety
Tickers EXAS GH
FDA Puts Brake On vTv Therapeutics' Diabetes Candidate Program, Including Late-Stage Study, Stock Tanks
Via Benzinga
Exposures Product Safety
Tickers VTVT
American Kratom Association Calls on the FDA To Be Fully Transparent and Accountable in Their Safety Alert on Kratom Products
Via EZ Newswire
Exposures Product Safety
BioMedNewsBreaks — Longeveron Inc. (NASDAQ: LGVN) Lomecel-B(TM) Study Results Presented at the Alzheimer’s Association International Conference
Via Investor Brand Network
Exposures Product Safety
Tickers LGVN
AGC Biologics’ Seattle Site Achieves Successful Multi-Product Inspection by U.S. Food and Drug Administration for Biologics License Applications
Via News Direct
Exposures Product Safety
< Previous 1 2
...
13 14 15 16 17 18 19 20 21
...
99 100 Next >
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
 
 
About Us | Contact Us | Privacy Policy | User Agreement | Advertise With Us | Site Map
Copyright © 2010-2020 Burlingame.com & California Media Partners, LLC. All rights reserved.